References
- Anderson S, Meyer T W, Rennke H G, Brenner B M. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612–9
- Meyer T W, Anderson S, Rennke H G, Brenner B M. Converting enzyme inhibitor therapy limits Enalapril and anaemia 617 progressive glomerular injury in rats with renal insufficiency. Am J Med 1985; 79(3C)31–6
- Meyer T W, Anderson S, Rennke H G, Brenner B M. Control of glomerular hypertension retards progression of established glomerular injury in rats with renal ablation. Kidney Int 1985; 27: 247a
- Anderson S, Rennke H G, Brenner B M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000
- Zatz R, Dunn R, Meyer T W, Anderson S, Rennke H G, Brenner B M. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–30
- Reams G P, Bauer J H. Effects of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. Arch Intern Med 1986; 146: 2145–8
- Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471–4
- Gould A B, Goodman S, De Wolf R, Onesti G, Swartz C. Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 1980; 96: 523–34
- Nielsen O J. Determination of human erythropoietin by radioimmunoassay. Method and clinical data. Clin Chim Acta 1988; 176: 303–14
- Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271–4
- Brøchner-Mortensen J. A simple single injection method for determination of the extracellular volume. Scand J Clin Lab Invest 1980; 40: 567–73
- Anagnostou A, Kurtzman N A. Hematological Consequences of Renal Failure. The Kidney, B M Brenner, F C Rector. WB Saunders, Philadelphia 1986; 1631–56
- Walle A J, Wong G Y, Demons G K, Garcia J F, Niedermayer W. Erythropoietin-hematocrit feedback circuit in the anaemia of end-stage renal disease. Kidney Int 1987; 31: 1205–9
- Onoyama K, Motomura K, Makita H, et al. Effects of long-term captopril on angiotensin II and erythropoietin levels and recovery from hemorrhagic anemia in rats. Cur Ther Res 1987; 41: 472–7
- Hirakata H, Onoyama K, Iseki K, Kumagai H, Fujimi S, Omae T. Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am J Nephrol 1984; 4: 355–60
- Hirakata H, Onoyama K, Hori K, Fujishima M. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Clin Nephrol 1986; 26: 27–32
- Onoyama K, Sanai T, Motomura K, Fujishima M. Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients. J Cardiovasc Pharmacol 1989; 13: S27–30
- Fyhrquist F, Karppinen K, Honkanen T, Saijonmaa O, Rosenlof K. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. J Int Med 1989; 226: 257–60
- Erslev A. Erythropoietin coming of age. N Engl J Med 1987; 316: 101–3
- Eckardt K-U, Kurtz A, Bauer C. Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol 1989; 25: F942–7